Subcutaneous insulin resistance successfully circumvented on long term by peritoneal insulin delivery from an implantable pump in four diabetic patients.

Riveline, J P; Vantyghem, M C; Fermon, C; Brunet, C; Gautier, J F; Renard, E; Charpentier, G

Riveline, J P; Vantyghem, M C; Fermon, C; Brunet, C; Gautier, J F; Renard, E; Charpentier, G.

Affiliation

Riveline JP; Service de diabétologie et endocrinologie, Hôpital Sud-Francilien, Corbeil-Essonnes, France. jeanpierre.riveline@ch-sud-francilien.fr

Diabetes Metab ; 31(5): 496-8, 2005 Nov.

Article in En | MEDLINE | ID: mdl-16357794

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 1/physiopathology; Insulin Resistance/physiology; Insulin/administration & dosage; Insulin/therapeutic use; Adult; Blood Glucose/metabolism; Diabetes Mellitus, Type 1/blood; Female; Humans; Hypoglycemic Agents/administration & dosage; Hypoglycemic Agents/therapeutic use; Injections, Intraperitoneal; Injections, Subcutaneous; Insulin Infusion Systems; Male

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Insulin Resistance / Diabetes Mellitus, Type 1 / Insulin Limits: Adult / Female / Humans / Male Language: En Year: 2005 Type: Article

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Insulin Resistance / Diabetes Mellitus, Type 1 / Insulin Limits: Adult / Female / Humans / Male Language: En Year: 2005 Type: Article